Aging Analytics Agency is the world’s premier provider of industry analytics on the topics of Longevity, Precision Preventive Medicine and Economics of Ageing, renowned for its development of sophisticated comparative analytical frameworks allowing for practical and tangible forecasts to be applied to industries that are otherwise too complex for standard analytical approaches to be used in a relevant way. The company provides strategic consulting services in fields relating to Longevity, and currently serves as the primary source of analytics and data for the UK All-Party Parliamentary Group for Longevity.
Deep Knowledge Ventures Swiss is the Switzerland-based subsidiary of Deep Knowledge Ventures, a leading investment fund focused on the synergetic convergence of DeepTech verticals, frontier technologies and technological megatrends, renowned for its use of sophisticated analytical systems for investment target identification and due-diligence. It made its first investments in the Longevity Industry in 2014, at a time when the large majority of investors still failed to consider it a serious prospect.
Biogerontology Research Foundation is the UK’s charity focused on Longevity and on expediting the coming paradigm shift from disease treatment to personalized precision prevention. It was the main initial donor that provided financial and organisational support to Longevity International UK for the purpose of establishing the APPG for Longevity. It was also actively involved in the successful initiative of adding a new extension code for “ageing-related diseases” accepted in 2018 by the World Health Organization during the last revisions of its International Classification of Diseases framework.
Longevity.International is an online interactive database of longevity scientists, companies, and investors. This platform allows different stakeholders in the longevity industry to connect, network, research and analyze. On the next stage this platform will also employ cutting-edge data visualization software and a networking section where various stakeholders within the longevity industry can connect and collaborate, where longevity companies are matched with the right investors, and where scientists can make contributions.